S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
Log in

Cortexyme News Headlines (NASDAQ:CRTX)

$52.41
-1.97 (-3.62 %)
(As of 02/26/2020 04:00 PM ET)
Today's Range
$50.71
Now: $52.41
$60.21
50-Day Range
$42.98
MA: $55.92
$72.51
52-Week Range
$19.35
Now: $52.41
$73.84
Volume123,562 shs
Average Volume164,667 shs
Market Capitalization$1.41 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Cortexyme (NASDAQ CRTX) News Headlines

Source:
DateHeadline
Cortexyme, Inc. (NASDAQ:CRTX) Receives Consensus Rating of "Hold" from BrokeragesCortexyme, Inc. (NASDAQ:CRTX) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - February 26 at 5:58 PM
Stock To Watch: Cortexyme (CRTX) Stock To Watch: Cortexyme (CRTX)
www.rttnews.com - February 16 at 11:54 PM
Cortexyme, Inc. (NASDAQ:CRTX) Sees Large Drop in Short InterestCortexyme, Inc. (NASDAQ:CRTX) Sees Large Drop in Short Interest
www.americanbankingnews.com - February 14 at 8:17 PM
Cortexyme Provides Regulatory Update for COR388 Development Program in Alzheimer’s DiseaseCortexyme Provides Regulatory Update for COR388 Development Program in Alzheimer’s Disease
finance.yahoo.com - February 13 at 8:06 AM
Cortexyme Announces Closing of $125 Million Private PlacementCortexyme Announces Closing of $125 Million Private Placement
finance.yahoo.com - February 10 at 4:17 PM
Cortexyme (NASDAQ:CRTX) & Gamida Cell (NASDAQ:GMDA) Critical SurveyCortexyme (NASDAQ:CRTX) & Gamida Cell (NASDAQ:GMDA) Critical Survey
www.americanbankingnews.com - February 8 at 2:16 AM
Cortexyme Announces $125 Million Private PlacementCortexyme Announces $125 Million Private Placement
www.businesswire.com - February 5 at 10:38 PM
Cortexyme, Inc. (NASDAQ:CRTX) Given Consensus Recommendation of "Hold" by BrokeragesCortexyme, Inc. (NASDAQ:CRTX) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - February 1 at 8:00 PM
Cortexyme Announces Publication of New Data Further Demonstrating the Therapeutic Potential of COR388, the Company’s Lead Investigational MedicineCortexyme Announces Publication of New Data Further Demonstrating the Therapeutic Potential of COR388, the Company’s Lead Investigational Medicine
finance.yahoo.com - January 30 at 12:48 PM
Cortexyme Announces the Initiation of an Open-Label Extension Study for the GAIN Trial of COR388 in Alzheimer’s DiseaseCortexyme Announces the Initiation of an Open-Label Extension Study for the GAIN Trial of COR388 in Alzheimer’s Disease
finance.yahoo.com - January 13 at 4:22 PM
Cortexyme to Present at the 3rd Annual Neuroscience Innovation Forum on January 12, 2020Cortexyme to Present at the 3rd Annual Neuroscience Innovation Forum on January 12, 2020
finance.yahoo.com - January 8 at 5:17 PM
Here's Why We're Not Too Worried About Cortexyme's (NASDAQ:CRTX) Cash Burn SituationHere's Why We're Not Too Worried About Cortexyme's (NASDAQ:CRTX) Cash Burn Situation
finance.yahoo.com - January 5 at 3:51 PM
Why Has Cortexyme’s Stock Jumped 2.5x So Far This MonthWhy Has Cortexyme’s Stock Jumped 2.5x So Far This Month
www.forbes.com - December 27 at 10:40 AM
Hedge Funds Have Never Been This Bullish On Cortexyme, Inc. (CRTX)Hedge Funds Have Never Been This Bullish On Cortexyme, Inc. (CRTX)
finance.yahoo.com - December 22 at 7:17 PM
The Zacks Analyst Blog Highlights: Alibaba, Beyond Meat, Cortexyme, Revolve and UberThe Zacks Analyst Blog Highlights: Alibaba, Beyond Meat, Cortexyme, Revolve and Uber
finance.yahoo.com - December 13 at 11:52 AM
Biogens shares drop on critical view of Alzheimers dataBiogen's shares drop on critical view of Alzheimer's data
www.msn.com - December 2 at 5:21 PM
Biogen's shares drop on critical view of Alzheimer's dataBiogen's shares drop on critical view of Alzheimer's data
finance.yahoo.com - December 2 at 5:21 PM
Cortexyme up 27% ahead of Evercore eventCortexyme up 27% ahead of Evercore event
seekingalpha.com - December 2 at 12:01 PM
Cortexyme to Present at the Evercore ISI 2nd Annual HealthCONx Conference on December 3, 2019Cortexyme to Present at the Evercore ISI 2nd Annual HealthCONx Conference on December 3, 2019
finance.yahoo.com - November 26 at 7:27 PM
Cortexyme Announces Third Quarter 2019 Financial Results and Provides Business UpdateCortexyme Announces Third Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - November 12 at 6:39 PM
The Zacks Analyst Blog Highlights: Zoom Video Communications, Beyond Meat, Turning Point Therapeutics and CortexymeThe Zacks Analyst Blog Highlights: Zoom Video Communications, Beyond Meat, Turning Point Therapeutics and Cortexyme
finance.yahoo.com - November 8 at 1:52 PM
Cortexyme Announces Oral Presentation on COR388 at Clinical Trials on Alzheimer’s Disease 2019Cortexyme Announces Oral Presentation on COR388 at Clinical Trials on Alzheimer’s Disease 2019
finance.yahoo.com - November 1 at 8:20 AM
Did Cortexyme, Inc. (NASDAQ:CRTX) Insiders Buy Up More Shares?Did Cortexyme, Inc. (NASDAQ:CRTX) Insiders Buy Up More Shares?
finance.yahoo.com - October 7 at 12:00 PM
Cortexyme Announces European Screening Now Underway in the Phase 2/3 GAIN TrialCortexyme Announces European Screening Now Underway in the Phase 2/3 GAIN Trial
finance.yahoo.com - September 26 at 5:40 PM
Scientists rethink Alzheimers, diversifying the drug searchScientists rethink Alzheimer's, diversifying the drug search
marketbeat.com - September 10 at 11:14 AM
What Percentage Of Cortexyme, Inc. (NASDAQ:CRTX) Shares Do Insiders Own?What Percentage Of Cortexyme, Inc. (NASDAQ:CRTX) Shares Do Insiders Own?
finance.yahoo.com - August 8 at 4:08 PM
Cortexyme to Present at the Canaccord Genuity Growth Conference on August 7thCortexyme to Present at the Canaccord Genuity Growth Conference on August 7th
finance.yahoo.com - July 31 at 6:10 PM
Cortexyme’s Approach to Addressing a Key Underlying Cause of Alzheimer’s Detailed at Alzheimer’s Association International Conference 2019Cortexyme’s Approach to Addressing a Key Underlying Cause of Alzheimer’s Detailed at Alzheimer’s Association International Conference 2019
finance.yahoo.com - July 17 at 11:52 AM
Cortexyme Announces Upcoming Data Presentations at the Alzheimer’s Association International Conference 2019Cortexyme Announces Upcoming Data Presentations at the Alzheimer’s Association International Conference 2019
finance.yahoo.com - July 10 at 11:19 AM
These Bay Area companies are part of an uptick in women-led IPOsThese Bay Area companies are part of an uptick in women-led IPOs
finance.yahoo.com - July 5 at 11:18 AM
Cortexyme's unique approach to Alzheimer's researchCortexyme's unique approach to Alzheimer's research
finance.yahoo.com - June 28 at 3:44 PM
Cortexyme Expands Clinical Advisory Board With Key Clinical and Regulatory ExpertsCortexyme Expands Clinical Advisory Board With Key Clinical and Regulatory Experts
finance.yahoo.com - June 19 at 10:03 AM
Cortexyme to Present at National Academies Forum on Tuesday, June 11, 2019Cortexyme to Present at National Academies Forum on Tuesday, June 11, 2019
finance.yahoo.com - June 10 at 12:16 PM
Cortexyme, Inc. Announces Pricing of Initial Public OfferingCortexyme, Inc. Announces Pricing of Initial Public Offering
finance.yahoo.com - May 20 at 4:04 PM
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel